The World Health Organization (WHO) has officially recommended more, this time two new drugs for the treatment of COVID-19, thus providing even more treatment options for the disease. As suggested by the WHO, the actual effectiveness of these drugs in saving the lives of COVID-19 patients will depend on their availability and affordability.
The first drug, baricitinib , is strongly recommended for patients with severe or critical COVID-19.
It belongs to a group of medicines called Janus kinase inhibitors (iJAK), which stop the immune system from being overstimulated. Baricitinib is an oral drug, so far known as a drug used in the treatment of rheumatoid arthritis. It is an alternative to other drugs for the treatment of arthritis belonging to the group of interleukin-6 receptor b...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
